Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - taugakerfi - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - afturköllun taugavöðvablokkunar sem valdið er af rócuronium eða vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - taugakerfi - Öll önnur lækningavörur - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
sugammadex hameln stungulyf, lausn 100 mg/ml
hameln pharma gmbh - sugammadex sodium - stungulyf, lausn - 100 mg/ml
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
bridion
merck sharp & dohme b.v. - sugammadex - taugakerfi - Öll önnur lækningavörur - afturköllun taugavöðvablokkunar sem valdið er af rócuronium eða vecuronium. fyrir peadiatric íbúafjöldi: sugammadex er einungis fyrir lífi viðsnúningur rocuronium völdum umsátur í börn og unglingar.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
byannli (previously paliperidone janssen-cilag international)
janssen-cilag international n.v. - paliperidon palmitat - geðklofa - psycholeptics - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
rixubis
baxalta innovations gmbh - nonacog gamma - hemophilia b - antihemorrhagics - meðferð og fyrirbyggja blæðingar í sjúklinga með dreyrasýki b (meðfædda þáttur laga skort).
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.